The Prognostic Impact of Additional Molecular and Cytogenetic Abnormalities on AML Patients with NPM1- And/or FLT3-ITD Mutations Receiving Intensive Chemotherapy: Real-World Data from the Greek Registry

Ioanna Lazana,Maria Papathanassiou, Ioannis Konstantellos,Tatiana Tzenou, Anastasia Kopsaftopoulou,Maria Liga, Vasiliki Violaki, Lydia Kyriazopoulou, Konstantinos Gkirkas,Apostolia Papalexandri,Eleni Plata, Evrydiki Michalis, Theoni Leonidopoulou, Maria Garofalaki, Anastasia Sioni, Irene Tziotziou, Chrysavgi Lalayanni, Dimitrios Kiousiafes,Theodoros P Vassilakopoulos,Eleni Kapsali,Alexandros Spyridonidis, Ioannis Baltadakis,Maria Angelopoulou,Ioanna Sakellari,Panagiotis Tsirigotis

Cancers（2025）

Cited 0|Views1

Key words

AML,NPM1,FLT3-ITD,MDS-related mutations,secondary mutations,cytogenetic abnormalities

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined